Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical investigation to move promising concepts toward potential patient impact.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Impact Grant - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology projects to explore new immunotherapy approaches and accelerate research in this disease.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
CLIN2 Awards: Funding Opportunity for Clinical Trials supports organizations conducting stem cell-based and genetic therapy trials to address serious unmet medical needs and advance therapies toward approval.
Clinical Research Investigator-Initiated Awards support investigators conducting clinical studies of Crohn’s disease and ulcerative colitis to improve patient care and change clinical practice.